Caroline Heckman

43PUBLICATIONS
242CO-AUTHORS
Predictive and prognostic markersHaematologyCharacterisation of biological macromoleculesMedical infection agents (incl. prions)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (43)

|Oct 02, 2026
A myeloid-dormant metabolic transcriptome identifies a poor-prognosis subgroup in hyperdiploid multiple myeloma with targetable vulnerabilities.

|Jun 18, 2026
Distinct stem cell identities converge into shared erythroid stress in ERCC6L2 disease and Shwachman-Diamond syndrome.

|Mar 26, 2026
Solubility based mechanistic profiling of combinatorial drug therapy.

Elham Gholizadeh, Ehsan Zangene, Uladzislau Vadadokhau

|Feb 27, 2026
Phosphoproteomic Profiling of Multiple Myeloma Based on Ex Vivo Drug Sensitivity Resistance Testing Identifies Phosphorylation Signatures Associated with Drug Response.

Katie Dunphy, Ellen Purcell, Caroline A Heckman

|Feb 05, 2026
Succinate receptor 1 restricts hematopoiesis and prevents acute myeloid leukemia progression.

Vincent Cuminetti, Emeline Boet, Marcel Heugel

|Jan 14, 2026
Drivers of clinical resistance to venetoclax and hypomethylating agents in acute myeloid leukemia and strategies for improving efficacy.

Ida Vänttinen, Joseph Saad, Tanja Ruokoranta

Pageof 8

Frequent Collaborators

11 joint publications

Juho Miettinen

8 joint publications

Joseph Saad

8 joint publications

Mika Kontro

5 joint publications

Tero Aittokallio